Surgery Partners' Q4 Earnings Report Causes Investor Concerns Over Declining EBITDA Surgery Partners' Q4 2025 earnings report showed a decline in adjusted EBITDA, leaving investors worried about future growth. The firm investigates potential legal actions.

Surgery Partners' Q4 Earnings Report Causes Investor Concerns Over Declining EBITDA #USA #New_York #Levi_Korsinsky #Surgery_Partners #SGRY

Ortelius Delivers Open Letter to Surgery Partners Stockholders Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc.. Ortelius Advisors, L.P. believes that Surgery Partners, Inc. has significant upside potential, based on its high-quality assets, favorable industry dynamics, and considerable free cash flow capabilities. However, we are deeply concerned by the Company’ s...

#SGRY Ortelius Delivers Open Letter to Surgery Partners Stockholders

www.stocktitan.net/news/SGRY/ortelius-deliv...

ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS Surgery Partners (NASDAQ: SGRY) acquired Preferred Vascular Group, an ambulatory surgical center operator focused on dialysis access procedures. PVG operates eight ASCs in Georgia and Ohio with 16 physicians and >160 employees. The deal gives Surgery Partners entry into the $6 billion dialysis access market with over two million procedures annually and retains PVG management to run the new operating entity.Ziegler served as exclusive financial advisor to PVG; legal counsel included Benesch for PVG and McDermott for Surgery Partners.

#SGRY ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS

www.stocktitan.net/news/SGRY/ziegler-advise...

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program Surgery Partners (NASDAQ:SGRY) reported fourth-quarter and full-year 2025 results and set 2026 guidance, while announcing a new share repurchase program. Full-year revenue rose to $3.3 billion (+6.2%) and Adjusted EBITDA reached $526.2 million (+3.5%).The company posted a full-year net loss attributable to Surgery Partners of $77.9 million, finished the year with $239.9 million in cash and $692.8 million of revolver capacity, and authorized up to $200 million in share repurchases. 2026 guidance targets Adjusted EBITDA of at least $530 million and revenue of $3.35–3.45 billion (ex-M&A).

#SGRY Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program

www.stocktitan.net/news/SGRY/surgery-partne...

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering Surgery Partners (NASDAQ:SGRY) priced an add-on offering of $425.0 million aggregate principal amount of 7.250% senior unsecured notes due 2032. The Issuer expects the offering to close on December 16, 2025, subject to customary closing conditions.The Notes will be guaranteed by each domestic wholly-owned subsidiary that guarantees the Issuer’s senior secured credit facilities and will be issued as part of the same series as the $800.0 million of 7.250% senior notes due 2032 issued in April 2024. Surgery Partners intends to use net proceeds for general corporate purposes, including repaying borrowings under its revolving credit facility. The offering is being made under Rule 144A and Regulation S.

#SGRY Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

www.stocktitan.net/news/SGRY/surgery-partne...

Pomerantz Law Firm Launches Investigation for Surgery Partners Investors Following Significant Stock Drop Pomerantz LLP is probing potential misdeeds by Surgery Partners, Inc. after a significant stock fall post-earnings announcement. Investors urged to connect.

Pomerantz Law Firm Launches Investigation for Surgery Partners Investors Following Significant Stock Drop #USA #New_York #Pomerantz_LLP #Surgery_Partners #SGRY

Surgery Partners, Inc. Announces Add-On Senior Notes Offering Surgery Partners (NASDAQ:SGRY) announced that subsidiary Surgery Center Holdings intends to offer an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032, to be issued as part of the same series as the April 2024 notes.The Notes will be guaranteed on a senior unsecured basis by each domestic wholly owned subsidiary that guarantees the issuer’s senior secured credit facilities. Net proceeds are intended for general corporate purposes, including possible repayment of outstanding borrowings under the company’s revolving credit facility. The offering will be limited to qualified institutional buyers (Rule 144A) in the U.S. and non-U.S. persons under Regulation S, and the Notes will not be registered under the Securities Act.

#SGRY Surgery Partners, Inc. Announces Add-On Senior Notes Offering

www.stocktitan.net/news/SGRY/surgery-partne...

Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care Surgery Partners (NASDAQ:SGRY) and Baylor Scott & White Health formed a joint venture announced Dec 08, 2025 to jointly own the 16-bed Physicians Centre Hospital in Bryan, Texas.The hospital will operate under the Baylor Scott & White name while Surgery Partners will continue day-to-day management. Patients can keep current providers. Services include bariatric, ophthalmologic, oral/maxillofacial, orthopedic, GI, podiatric, spinal, urologic, general, plastic/reconstructive surgery, sports medicine, pain management and radiology.

#SGRY Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care

www.stocktitan.net/news/SGRY/surgery-partne...

🚨 Institutions #optionsvolume surge detected! Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #FISV 3539.4x
2. #SGRY 701.2x
3. #CYPH 449.6x
4. #ACHC 224.8x
5. #NMG 62.2x

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #ABCL 10.9x
2. #PSKY 8.4x
3. #SGRY 4.1x
4. #NU 4.1x
5. #ONON 3.9x

#OptionFlow #OptionsTrading #Trading

#SGRY #^GSPC #4c1d4743-62e2-49f6-9188-052119c7c3cc #investing

Origin | Interest | Match

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #SGRY 3.7x
2. #PAAS 3.3x
3. #NVAX 2.6x
4. #CGBD 2.6x
5. #KSS 2.2x

#OptionFlow #OptionsTrading #Trading

Surgery Partners, Inc. Announces Third Quarter 2025 Results Surgery Partners (NASDAQ:SGRY) reported third quarter 2025 results for the period ended September 30, 2025. Revenue was $821.5 million, up 6.6% YoY; same-facility revenue rose 6.3%. Adjusted EBITDA was $136.4 million, up 6.1% YoY, while net loss attributable was $22.7 million. Year-to-date revenue was $2,423.7 million, up 7.7%, with YTD Adjusted EBITDA of $369.3 million. Liquidity included $203.4 million cash and $405.9 million revolver capacity. Leverage was ~4.2x net debt/EBITDA and 4.6x consolidated debt/Adj EBITDA. Full-year 2025 guidance: $3.275–3.30 billion revenue and $535–540 million Adjusted EBITDA.Management noted softer-than-expected volume and payor mix and delayed capital deployment as drivers of a prudent fourth-quarter outlook.

#SGRY Surgery Partners, Inc. Announces Third Quarter 2025 Results

www.stocktitan.net/news/SGRY/surgery-partne...

Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Details Surgery Partners (NASDAQ:SGRY) will release its third quarter 2025 results before the market opens on Monday, November 10, 2025, followed by a conference call at 8:30 a.m. ET.Live dial-in numbers: 1-877-451-6152 (domestic) and 1-201-389-0879 (international). A replay will be available three hours after the call until November 24, 2025 at 1-844-512-2921 (domestic) and 1-412-317-6671 (international). Passcode for live and replay: 13756022. A simultaneous webcast and replay will be available on the company Investor Relations website at www.surgerypartners.com.

#SGRY Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Details

www.stocktitan.net/news/SGRY/surgery-partne...

Surgery Partners, Inc. Announces Second Quarter 2025 Results Surgery Partners (NASDAQ:SGRY) reported strong Q2 2025 financial results, with revenue increasing 8.4% to $826.2 million and Adjusted EBITDA growing 9.0% to $129.0 million. Same-facility revenues rose 5.1%, driven by a 3.4% increase in cases and 1.6% growth in revenue per case.The company reaffirmed its full-year 2025 guidance, projecting revenue between $3.30-3.45 billion and Adjusted EBITDA of $555-565 million. Surgery Partners maintained strong liquidity with $250.1 million in cash and $394.9 million available under its revolving credit facility, while operating cash flow was $81.3 million for Q2 2025.

#SGRY Surgery Partners, Inc. Announces Second Quarter 2025 Results

www.stocktitan.net/news/SGRY/surgery-partne...

Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has scheduled its second quarter 2025 earnings release for Tuesday, August 5, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time to discuss the results.Investors can access the call via phone (1-844-826-3033 domestic, 1-412-317-5185 international) or through a simultaneous webcast on the Investor Relations section of Surgery Partners' website. A replay will be available for two weeks until August 19, 2025, using passcode 10201328.

#SGRY Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details

www.stocktitan.net/news/SGRY/surgery-partne...

VesselAlert
Name: RAMANDA
MMSI: 266457000
Callsign: SGRY
Type: Tanker
Flag: Sweden
Seen: 09-Jul-2025 15:32:21 CEST
Status: under way using engine
Speed: 7.8 kts
Heading: 75 deg
Dest.: DEBRB
Distance: 38.5 nm
Signal RSSI: -28.1 dBFS
Ship AIS VesselAlert © kx1t - link

SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions Surgery Partners (NASDAQ:SGRY) announced that discussions with Bain Capital regarding their proposal to acquire remaining outstanding shares have concluded without a deal. The Independent Committee determined that the company's prospects as a public entity exceeded Bain's proposal value. Surgery Partners reaffirmed its 2025 financial guidance, projecting revenues of $3.30-3.45 billion and Adjusted EBITDA of $555-565 million. The company plans to host an Investor Day in H2 2025 to present its growth strategy. Management expressed confidence in the company's positioning in the outpatient surgical care market, citing strong Q1 performance, favorable surgical trends, and a positive regulatory landscape. Bain Capital, while unable to reach agreement terms, remains optimistic about Surgery Partners' business and will continue as long-term investors.

#SGRY SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions

www.stocktitan.net/news/SGRY/surgery-partne...

Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance Surgery Partners (NASDAQ:SGRY) reported Q1 2025 results with revenue increasing 8.2% to $776.0 million. Same-facility revenues grew 5.2% with a 6.5% increase in cases, despite a slight decline in revenue per case. The company posted a net loss of $37.7 million but achieved Adjusted EBITDA growth of 6.6% to $103.9 million. Surgery Partners maintained its full-year 2025 guidance, projecting revenues of $3.30-3.45 billion and Adjusted EBITDA of $555-565 million. The company reported strong liquidity with $229.3 million in cash and $388.9 million in credit facility capacity, maintaining a net debt to EBITDA ratio of approximately 4.1x.

#SGRY Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance

www.stocktitan.net/news/SGRY/surgery-partne...

Can Surgery Partners' 13.5% Revenue Growth Overcome Its $168M Annual Loss? Surgery Partners posted strong Q4 revenue growth of 17.5% and projects continued expansion with 2025 revenue guidance of $3.30B-$3.45B despite ongoing net losses.

#SGRY Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance

www.stocktitan.net/news/SGRY/surgery-partne...

Major Healthcare Deal Alert: Surgery Partners Could Go Private in Multi-Billion Dollar Acquisition Surgery Partners evaluates $25.75 per share cash buyout proposal from Bain Capital to acquire remaining 61% stake. Special committee formed to review non-binding offer with shareholder approval required.

#SGRY Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital

www.stocktitan.net/news/SGRY/surgery-partne...

NEWS: ( NASDAQ: #SGRY ) Learn to Evaluate (SGRY) using the Charts

#StockMarket #News

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#UGI, #SGRY, #MRTN, #HBM, #GTES

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #H 5.1x
2. #UGI 4.1x
3. #VNDA 2.8x
4. #ARM 2.7x
5. #SGRY 2.5x

#OptionFlow #OptionsTrading #Trading